Status:

COMPLETED

Curcumin Associated With Thiopurin in the Prevention of Post-op Recurrence in Crohn Disease

Lead Sponsor:

University Hospital, Clermont-Ferrand

Collaborating Sponsors:

3i nature

Naturopôle Nutrition santé

Conditions:

Crohn's Disease

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

Curcumin, the active ingredient of turmeric, has been used for long term in the treatment of inflammatory conditions. Inhibition of NF-κB is postulated as the main mechanism responsible for the anti-i...

Detailed Description

122 subjects, operated on for Crohn disease, will be included in the study. After ileo-colonic resection, subjects will be randomized into two arms; they will be given either placebo or curcumin 3g/d ...

Eligibility Criteria

Inclusion

  • Crohn's disease confirmed by radiographic, endoscopic or histologic criteria
  • Age \> 18 yr
  • Affiliated to french health insurance
  • Operated on less than 15 days ago for ileal, colonic or ileo-colonic Crohn's disease with all macroscopic lesions being removed, with an anastomosis which can be reached by ileocolonoscopy

Exclusion

  • Ulcerative colitis
  • Pregnant or nursing woman
  • Refusal of contraceptive measure for childbearing potential, woman or fertile man
  • Indication of anti-TNFα treatment
  • Concomitant treatment including antibiotics, probiotics, mesalazine, methotrexate, cyclosporine, tacrolimus, anti-TNFα, ustekinumab, vedolizumab
  • Concomitant treatment with corticosteroids, except in case of tapering a treatment initiated before surgery
  • Renal insufficiency ( serum creatinine 2N)
  • Chronic hepatic disease except for primary sclerosing cholangitis
  • ALAT , ASAT, alkaline phosphatases, or bilirubin \> 3N
  • Current infection to HIV, HBV (except if HBV Ac positives), HCV
  • Contraindication to thiopurines
  • Unwillingness of the patient

Key Trial Info

Start Date :

December 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2018

Estimated Enrollment :

61 Patients enrolled

Trial Details

Trial ID

NCT02255370

Start Date

December 1 2014

End Date

June 1 2018

Last Update

December 28 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

CHU de Clermont-Ferrand

Clermont-Ferrand, France, 63003